Top Markets
Coin of the day
Destiny Pharma plc Destiny Pharma plc

Destiny Pharma plc

DEST
Rankning i aktier #41146
Destiny Pharma plc is a biotechnology company based in Brighton, UK, founded in... Destiny Pharma plc is a biotechnology company based in Brighton, UK, founded in 1996, specializing in the identification, progression, and market introduction of pharmaceutical solutions for infectious diseases. The company's clinical pipeline includes NTCD-M3, currently in Phase III trials to prevent recurring Clostridioides difficile infections. Its XF-73 program features XF-73 Nasal, undergoing Phase II development for the prevention of post-surgical staphylococcal infections, and XF-73 Dermal, which is in Phase I for treating bacterial skin infections resistant to antibiotics. Additionally, Destiny Pharma's preclinical efforts involve SPOR-COV, a biotherapeutic product aimed at preventing COVID-19 and other viral respiratory diseases, and XF Drugs Biofilm, targeting antibiotic-resistant biofilm and bacterial aggregate infections. The company is also investigating further applications of its XF drugs for respiratory, oral mucosa, and ocular infections. Destiny Pharma maintains strategic alliances with various organizations, including China Medical System Holdings Limited, SporeGen Limited, the University of Southampton, Aston University, the University of Sheffield, Cardiff University, and Tianjin Medical University.
Aktiekurs
$0.04082105
Senast synkroniserad: 2024-08-12
Marknadsvärde
$39.09K
Förändring (1 dag)
-19.83%
Förändring (1 år)
0.00%
Land
GB
Handel Destiny Pharma plc (DEST)

Kategori

Vinst för Destiny Pharma plc (DEST)
Vinst i Dec 2023 TTM: $-8.21M
Enligt de senaste finansiella rapporterna från Destiny Pharma plc är företagets nuvarande vinst $-8.21M. År 2022 hade företaget en vinst på $-9.33M, en minskning jämfört med vinsten år 2021 som var $-8.48M. Vinsten som visas på denna sida är vinsten före räntor och skatt, även kallad EBIT.
Vinshistorik för Destiny Pharma plc från 2013 till 2026
Vinst vid slutet av varje år
År Vinst Ändra
2026 (TTM) $-8.21M 0.00%
2023 $-8.21M -12.04%
2022 $-9.33M 10.03%
2021 $-8.48M -4.31%
2020 $-8.86M 21.02%
2019 $-7.32M -4.32%
2018 $-7.65M 76.32%
2017 $-4.34M 142.61%
2016 $-1.79M 1.42%
2015 $-1.76M -45.18%
2014 $-3.22M 174.64%
2013 $-1.17M 0.00%
Vinst för liknande företag eller konkurrenter
Företag Vinst Skillnad i vinst Land
$5.27B -64,380.54%
US
$1.95B -23,870.85%
NL
- -
CH
- -
KR
$3.01B -36,728.02%
BE